480450-85-9 Usage
Molecular structure
The compound has a complex molecular structure with multiple functional groups, including a cyclohexylamine group, a tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl group, a dimethylamino carbonyl group, an ethyl ester group, and an oxoacetic acid group.
Synthetic organic molecule
The compound is a synthetic organic molecule, meaning it is artificially created in a laboratory setting rather than being found naturally occurring in nature.
Biological activity
The compound is capable of binding to and affecting various biological processes, suggesting potential applications in the field of medicinal chemistry or pharmacology.
Potential applications
Due to its ability to interact with biological systems, the compound may serve as a chemical agent for further study and development in areas such as drug discovery and therapeutic intervention.
Solubility
The presence of the ethyl ester group in the compound may influence its solubility properties, making it more soluble in organic solvents and less soluble in water.
Stability
The compound's stability may be influenced by the presence of various functional groups, which can affect its reactivity and resistance to degradation under different environmental conditions.
Structural complexity
The compound's long and intricate name reflects its complex structure, which may pose challenges in terms of synthesis, purification, and characterization.
Check Digit Verification of cas no
The CAS Registry Mumber 480450-85-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,8,0,4,5 and 0 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 480450-85:
(8*4)+(7*8)+(6*0)+(5*4)+(4*5)+(3*0)+(2*8)+(1*5)=149
149 % 10 = 9
So 480450-85-9 is a valid CAS Registry Number.
480450-85-9Relevant academic research and scientific papers
DIAMINE DERIVATIVES
-
Page 186, (2008/06/13)
A compound represented by the general formula (1):Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4 wherein R1 and R2 are hydrogen atoms or the like; Q1 is a saturated or unsaturated, 5- or 6- membered cyclic hydrocarbon group which may be substituted, or the like; Q2 is a single bond or the like; Q3 is a group in which Q5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T0 and T1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
